| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.41 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |